Figure 3.
Figure 3. Kaplan-Meier product limit estimate of disease-free survival (DFS) from the time of complete response (CR).Reprinted with permission from Sanz M, Martin G, Rayon C, et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia. Blood. 1999;94:3015–3021.

Kaplan-Meier product limit estimate of disease-free survival (DFS) from the time of complete response (CR).Reprinted with permission from

Sanz M, Martin G, Rayon C, et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia. Blood. 1999;94:3015–3021.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal